ENVB ▲ +2.7% - Enveric Biosciences, Inc. $ENVB - Enveric Biosciences Secures New U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series Enveric Biosciences rose 2.7% after securing a new U.S. patent allowance for its EVM401 series of non-hallucinogenic mescaline derivatives. The patent protection for its next-generation compounds strengthens the company's intellectual property position in its psychedelic-derived therapeutic development pipeline. 15-SEP-2026 08:05 AM ET